We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+6.71%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$2.38B
AUM Growth
+$16.2M
Cap. Flow
-$65.9M
Cap. Flow %
-2.78%
Top 10 Hldgs %
48.01%
Holding
72
New
8
Increased
36
Reduced
21
Closed
6

Top Buys

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$33M
2
MDVN
MEDIVATION, INC.
MDVN
+$27.8M
3
PFE icon
Pfizer
PFE
+$24.4M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$13.8M
5
AGN
Allergan Inc
AGN
+$13.6M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$71.4M
2
ILMN icon
Illumina
ILMN
+$44.1M
3
SHPG
Shire pic
SHPG
+$39.5M
4
MRK icon
Merck
MRK
+$37.9M
5
GILD icon
Gilead Sciences
GILD
+$18.5M

Sector Composition

Rank Sector Weight
1 Healthcare 89.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
1
Biogen
BIIB
$30.4B
$170M 7.16%
514,406
-46,973
-8% -$15.5M
AMGN icon
2
Amgen
AMGN
$198B
$165M 6.96%
1,177,201
-17,964
-2% -$2.35M
GILD icon
3
Gilead Sciences
GILD
$167B
$139M 5.87%
1,309,916
-189,200
-13% -$18.5M
CELG
4
DELISTED
Celgene Corp
CELG
$129M 5.44%
1,364,772
+114,100
+9% +$10.3M
BMRN icon
5
BioMarin Pharmaceuticals
BMRN
$11.5B
$99.5M 4.19%
1,379,000
+210,496
+18% +$13.8M
VTRS icon
6
Viatris
VTRS
$20.1B
$98.3M 4.13%
2,159,851
+679,869
+46% +$33M
TEVA icon
7
Teva Pharmaceuticals
TEVA
$37.3B
$91.8M 3.86%
1,708,191
+195,604
+13% +$10.4M
AGN
8
DELISTED
Allergan plc
AGN
$83.9M 3.53%
347,850
+8,400
+2% +$1.88M
REGN icon
9
Regeneron Pharmaceuticals
REGN
$70.9B
$82.1M 3.46%
227,800
-100
-0% -$33.5K
ALXN
10
DELISTED
Alexion Pharmaceuticals
ALXN
$80.8M 3.4%
487,408
-1,700
-0.3% -$279K
INCY icon
11
Incyte
INCY
$23.4B
$80M 3.37%
1,631,812
+60,360
+4% +$3.03M
TMO icon
12
Thermo Fisher Scientific
TMO
$198B
$63.8M 2.69%
524,600
+84,300
+19% +$10.2M
PTCT icon
13
PTC Therapeutics
PTCT
$6.52B
$58.2M 2.45%
1,322,398
-228,876
-15% -$7.16M
PRGO icon
14
Perrigo
PRGO
$1.48B
$55.2M 2.32%
367,568
+16,200
+5% +$2.42M
MNK
15
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$54.1M 2.28%
600,464
+118,900
+25% +$9.3M
KERX
16
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$49.7M 2.09%
3,615,126
-126,530
-3% -$1.94M
AGN
17
DELISTED
Allergan Inc
AGN
$48.8M 2.05%
273,650
+81,600
+42% +$13.6M
NPSP
18
DELISTED
NPS PHARMACEUTICALS INC
NPSP
$44.9M 1.89%
1,726,824
+146,730
+9% +$4.21M
HALO icon
19
Halozyme
HALO
$9.23B
$41.5M 1.75%
4,558,982
+169,300
+4% +$1.61M
GEVA
20
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
$41.4M 1.74%
602,345
+85,900
+17% +$6.15M
RDY icon
21
Dr. Reddy's Laboratories
RDY
$10.5B
$38.6M 1.63%
3,674,735
+1,125,150
+44% +$10.6M
VRTX icon
22
Vertex Pharmaceuticals
VRTX
$123B
$37.1M 1.56%
329,897
-749,567
-69% -$71.4M
PTLA
23
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$35.7M 1.5%
1,412,350
+47,198
+3% +$1.24M
MDVN
24
DELISTED
MEDIVATION, INC.
MDVN
$33.3M 1.4%
673,756
+653,290
+3,192% +$27.8M
OMED
25
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$32.1M 1.35%
1,694,517
+302,032
+22% +$6.07M
1
2 3

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
CCM
Chicago Capital Management Chicago, Illinois $121M AUM 74.36% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
FWA
Fulcrum Wealth Advisors Bellevue, Washington $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM

Sectoral Asset Management's Q3 2014 Portfolio in Review

As of Q3 2014, Sectoral Asset Management held 72 positions worth $2.38B, up 0.69% from $2.36B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Sectoral Asset Management's Q3 2014 filing shows 8 new, 36 increased, 21 reduced and 6 closed positions. Its largest new stake was Pfizer: 868,442 shares worth $24.4M. The largest sale was Vertex Pharmaceuticals, an estimated $71.4M.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, down from 90% a quarter earlier.

  • Sectoral Asset Management's largest Q3 2014 buy was Pfizer: 868,442 shares worth $24.4M.
  • Sectoral Asset Management added most to Viatris in Q3 2014, an estimated $33M increase.
  • Sectoral Asset Management's biggest Q3 2014 reduction was Vertex Pharmaceuticals, cutting an estimated $71.4M.
  • Sectoral Asset Management fully exited Illumina in Q3 2014, selling an estimated $44.1M.
  • Sectoral Asset Management's ten largest holdings make up 48% of its $2.38B portfolio in Q3 2014.
  • Sectoral Asset Management opened 8 new positions and closed 6 in Q3 2014.
  • Sectoral Asset Management's portfolio value rose 0.69% quarter-over-quarter to $2.38B.

Based on Sectoral Asset Management's 13F filing for Q3 2014, filed 13 Nov 2014.